Shopping Cart
Remove All
Your shopping cart is currently empty
Hersintuzumab is a humanized monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2/ErbB2). By specifically binding to the extracellular domain of HER2, it blocks downstream proliferative signaling pathways (e.g., PI3K/Akt) and mediates antibody-dependent cellular cytotoxicity (ADCC), making it widely used to research therapeutic strategies for HER2-positive malignancies like breast and gastric cancers.

| Description | Hersintuzumab is a humanized monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2/ErbB2). By specifically binding to the extracellular domain of HER2, it blocks downstream proliferative signaling pathways (e.g., PI3K/Akt) and mediates antibody-dependent cellular cytotoxicity (ADCC), making it widely used to research therapeutic strategies for HER2-positive malignancies like breast and gastric cancers. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | ERBB2/HER2/CD340 |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.